Don Ronning

Don Ronning is a Professor at the University of Nebraska Medical Center (UNMC) in the Department of Pharmaceutical Sciences, College of Pharmacy. He also serves as Director of the Pharmaceutical Sciences Graduate Program and contributes to research in anti-infective and anti-cancer drug discovery.

• Institution: University of Nebraska Medical Center
• Role: Director, Pharmaceutical Sciences Graduate Program
• Contact: Phone 402-559-6293, Fax 402-559-5673

Dr. Ronning’s research focuses on anti-infective and anti-cancer compound development. Key areas include:

• Tuberculosis: Targeting bacterial proteins via structural characterization and enzyme kinetics to identify inhibitors.
• Ovarian Cancer: Investigating DNA repair mechanisms and novel therapeutic strategies.
• Medulloblastoma: Optimizing lead compounds for treatment.

Recent publications highlight trends in:

• AI in Drug Screening (2024) for anti-infective and cancer applications.
• Phosphodiesterase Inhibition (2025) for liver injury and metabolic diseases.
• Structural Biology (2023) in M. tuberculosis enzyme systems.

Laboratory resources are hosted at UNMC, with a focus on interdisciplinary approaches to protein function and inhibitor design.